Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Combination Hydroxyurea and Exogenous Erythropoietin in Sickle Cell Disease

NCT05451940 is registered in ClinicalTrials.gov with Julia Xu as lead sponsor.

NCT NCT05451940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05451940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Combination Hydroxyurea and Exogenous Erythropoietin in Sickle Cell Disease
Lead sponsor
Julia Xu
Phase
Phase 1/2
Overall status
Completed
Start date
May 25, 2023
Completion date
February 27, 2025
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, sickle cell, sickle cell disease